Potential pharmacological approach in the regulation of ACE-2 and DPP-IV in diabetic COVID-19 patient
The global pandemic caused by COVID-19 has caused more than 1 million deaths worldwide. Some vaccines in clinical trials have reached stage 3. In the meantime, the understanding of the biological and pathophysiological mechanisms of Sars-CoV2 infection is still unclear, such as the role that ACE-2 a...
Main Authors: | Francesco Ferrara, Antonio Vitiello |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-12-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | https://www.italjmed.org/index.php/ijm/article/view/1435 |
Similar Items
-
Integrated Evaluation of the Multifunctional DPP-IV and ACE Inhibitory Effect of Soybean and Pea Protein Hydrolysates
by: Carlotta Bollati, et al.
Published: (2022-06-01) -
Chemical and biological characterization of spirulina protein hydrolysates: Focus on ACE and DPP-IV activities modulation
by: Gilda Aiello, et al.
Published: (2019-12-01) -
Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection
by: Antonio Vitiello, et al.
Published: (2022-06-01) -
Integrated Evaluation of Dual-Functional DPP-IV and ACE Inhibitory Effects of Peptides Derived from Sericin Hydrolysis and Their Stabilities during In Vitro-Simulated Gastrointestinal and Plasmin Digestions
by: Papungkorn Sangsawad, et al.
Published: (2022-12-01) -
Investigation of <i>Chlorella pyrenoidosa</i> Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides
by: Yuchen Li, et al.
Published: (2021-05-01)